| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.42 | 0.002 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |